Ansell Ltd
ASX:ANN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.97
32.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Ansell Ltd
Ansell Ltd
Cash & Cash Equivalents
Ansell Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ansell Ltd
ASX:ANN
|
Cash & Cash Equivalents
$185.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-5%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Cash & Cash Equivalents
AU$23.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Polynovo Ltd
ASX:PNV
|
Cash & Cash Equivalents
AU$45.9m
|
CAGR 3-Years
81%
|
CAGR 5-Years
27%
|
CAGR 10-Years
55%
|
|
|
SDI Ltd
ASX:SDI
|
Cash & Cash Equivalents
AU$6.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Cash & Cash Equivalents
AU$30.8m
|
CAGR 3-Years
94%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Next Science Ltd
ASX:NXS
|
Cash & Cash Equivalents
$9.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Ansell Ltd
Glance View
Ansell Ltd. engages in the development, manufacture, distribution, and sale of gloves and protective personal equipment in the industrial and medical end markets. The company is headquartered in Richmond, Victoria and currently employs 14,159 full-time employees. The company is engaged in development, manufacturing, sourcing, and distributing of gloves and personal protective equipments. The firm operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Industrial GBU manufactures hand and chemical protective clothing solutions for industrial applications. Industrial GBU offers protective solutions to various industries such as automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil, and gas. Healthcare GBU manufactures surgical and examination gloves, healthcare safety devices and infection prevention products for healthcare professionals and patients and single use industrial application gloves. Healthcare GBU offers solutions to customers including hospitals, dental surgeries, veterinary clinics, auto repair shops, chemical plants, laboratories, and pharmaceutical companies.
See Also
What is Ansell Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
185.5m
USD
Based on the financial report for Jun 30, 2024, Ansell Ltd's Cash & Cash Equivalents amounts to 185.5m USD.
What is Ansell Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-5%
Over the last year, the Cash & Cash Equivalents growth was 181%. The average annual Cash & Cash Equivalents growth rates for Ansell Ltd have been -7% over the past three years , -14% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
